Sepesi, Boris
The University of Texas MD Anderson Cancer Center
11 papers on CoChatORCID 0000-0003-1442-611X
Most cited papers
- Verified
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
Gomez, D. R., Blumenschein, G. R., Lee, J. J., Hernandez, M., Ye, R., Camidge, D. R., Doebele, R. C., Skoulidis, F., Gaspar, L. E., Gibbons, D. L., et al. (2016) · The Lancet Oncology
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 1,086
- Verified
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Cascone, T., William, W. N., Weissferdt, A., Leung, C. H., Lin, H. Y., Pataer, A., Godoy, M. C. B., Carter, B. W., Federico, L., Reuben, A., et al. (2021) · Nature Medicine
Cancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment
Cited by 618
- Verified
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma
Goswami, S., Walle, T., Cornish, A. E., Basu, S., Anandhan, S., Fernandez, I., Vence, L., Blando, J., Zhao, H., Yadav, S. S., et al. (2020) · Nature Medicine
Cancer Immunotherapy and BiomarkersGlioma Diagnosis and Treatment
Cited by 356
- Verified
Comprehensive T cell repertoire characterization of non-small cell lung cancer
Reuben, A., Zhang, J., Chiou, S.-H., Gittelman, R. M., Li, J., Lee, W.-C., Fujimoto, J., Behrens, C., Liu, X., Wang, F., et al. (2020) · Nature Communications
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 220
- Verified
Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer
Tang, C., Hobbs, B., Amer, A., Li, X., Behrens, C., Canales, J. R., Cuentas, E. P., Villalobos, P., Fried, D., Chang, J. Y., et al. (2018) · Scientific Reports
Radiomics and Machine Learning in Medical ImagingCancer Immunotherapy and Biomarkers
Cited by 154
- Verified
Diets enriched in foods with high antioxidant activity reverse age-induced decreases in cerebellar β-adrenergic function and increases in proinflammatory cytokines
Gemma, C., Mesches, M. H., Sepesi, B., Choo, K., Holmes, D. B., & Bickford, P. C. (2002) · The Journal of Neuroscience
Antioxidant Activity and Oxidative StressPhytochemicals and Antioxidant Activities
Cited by 143
- Verified
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study
Saad, M. B., Hong, L., Aminu, M., Vokes, N. I., Chen, P., Salehjahromi, M., Qin, K., Sujit, S. J., Lu, X., Young, E., et al. (2023) · The Lancet Digital Health
Radiomics and Machine Learning in Medical ImagingCancer Immunotherapy and Biomarkers
Cited by 121
- Verified
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy
Weissferdt, A., Pataer, A., Vaporciyan, A. A., Correa, A. M., Sepesi, B., Moran, C. A., Wistuba, I. I., Roth, J. A., Shewale, J. B., Heymach, J. V., et al. (2020) · Clinical Lung Cancer
Lung Cancer Diagnosis and TreatmentLung Cancer Research Studies
Cited by 113
- Verified
Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer
Cascone, T., Gold, K. A., Swisher, S. G., Liu, D. D., Fossella, F. V., Sepesi, B., Pataer, A., Weissferdt, A., Kalhor, N., Vaporciyan, A. A., et al. (2018) · The Annals of Thoracic Surgery
Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations
Cited by 32
- Verified
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel and Nintedanib for Resectable Non-Small Cell Lung Cancer
Cascone, T., Sepesi, B., Lin, H. Y., Kalhor, N., Parra, E. R., Jiang, M., Godoy, M. C. B., Zhang, J., Fossella, F. V., Tsao, A. S., et al. (2020) · Clinical Cancer Research
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 31
- Verified
P2.04-90 Nodal Immune Flare (NIF) Following Neoadjuvant Anti-PD-1 and Anti-CTLA-4 Therapy in Non-Small Cell Lung Cancer
Sepesi, B., Godoy, M., William, W., Vaporciyan, A., Lin, H., Leung, C., Lee, J., Mitchell, K., Weissferdt, A., Le, X., et al. (2019) · Journal of Thoracic Oncology
Cancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free